Page last updated: 2024-08-24

cidofovir anhydrous and Myelodysplastic Syndromes

cidofovir anhydrous has been researched along with Myelodysplastic Syndromes in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Edelmann, A; Hofmann, J; Kühl, JS; Sauerbrei, A; Voigt, S	1
de Villiers, EM; Gröne, D; Husak, R; Orfanos, CE; Treudler, R; Zouboulis, ChC	1
Basara, N; Kiehl, MG	1

Trials

1 trial(s) available for cidofovir anhydrous and Myelodysplastic Syndromes

Article	Year
Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients. Blood, 2001, Sep-01, Volume: 98, Issue:5 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Myelodysplastic Syndromes; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Transplantation, Homologous; Treatment Failure; Viremia; Virus Activation	2001

Article

Year

Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.

Blood, 2001, Sep-01, Volume: 98, Issue:5

Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Myelodysplastic Syndromes; Organophosphonates; Organophosphorus Compounds; Prospective Studies; Transplantation, Homologous; Treatment Failure; Viremia; Virus Activation

2001

Other Studies

2 other study(ies) available for cidofovir anhydrous and Myelodysplastic Syndromes

Article	Year
Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5 Topics: Acyclovir; Adenoviridae; Adenovirus Infections, Human; Antibiotic Prophylaxis; Antiviral Agents; Child, Preschool; Cidofovir; Cytosine; DNA, Viral; Drug Resistance, Viral; Epstein-Barr Virus Infections; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpes Zoster; Herpesvirus 1, Human; Herpesvirus 3, Human; Herpesvirus 4, Human; Humans; Immunocompromised Host; Meningoencephalitis; Mucositis; Myelodysplastic Syndromes; Organophosphonates; Rituximab; Viral Load	2016
Intravenous cidofovir treatment for recalcitrant warts in the setting of a patient with myelodysplastic syndrome. Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:2 Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Diagnosis, Differential; Female; Hand; Humans; Infusions, Intravenous; Myelodysplastic Syndromes; Organophosphonates; Skin Diseases; Warts	2006

Article

Year

Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.

Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5

Topics: Acyclovir; Adenoviridae; Adenovirus Infections, Human; Antibiotic Prophylaxis; Antiviral Agents; Child, Preschool; Cidofovir; Cytosine; DNA, Viral; Drug Resistance, Viral; Epstein-Barr Virus Infections; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpes Zoster; Herpesvirus 1, Human; Herpesvirus 3, Human; Herpesvirus 4, Human; Humans; Immunocompromised Host; Meningoencephalitis; Mucositis; Myelodysplastic Syndromes; Organophosphonates; Rituximab; Viral Load

2016

Intravenous cidofovir treatment for recalcitrant warts in the setting of a patient with myelodysplastic syndrome.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:2

Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Diagnosis, Differential; Female; Hand; Humans; Infusions, Intravenous; Myelodysplastic Syndromes; Organophosphonates; Skin Diseases; Warts

2006